Phoenix Venture Partners LLC is a venture capital firm headquartered in San Mateo, California, with additional offices in Singapore and Cambridge, Massachusetts. Founded in 2009, the firm specializes in investing in startups and growth capital, primarily focusing on technologies and advanced materials. Its investment areas encompass a wide range of sectors, including novel materials, optics, healthcare, pharmaceuticals, consumer electronics, energy generation, and the Internet of Things. The firm aims to partner with entrepreneurs to commercialize breakthrough innovations in materials science, offering support in business development, customer and supply chain partnerships, and operational strategies. Phoenix Venture Partners primarily targets investments in North America but also explores opportunities in Europe, Asia, Central America, Mexico, and the Caribbean.
UbiQD, LLC is a manufacturer of low-hazard semiconductor nanocrystals based in Los Alamos, New Mexico. Founded in 2014, the company specializes in producing low-toxicity quantum dots and polymer composites that are designed for a variety of applications, including agriculture, solar energy, and lighting. One of its key products, UbiGro, is a retrofit luminescent film that can be easily installed in greenhouses to enhance crop growth by optimizing sunlight. UbiQD's focus on creating inexpensive, cadmium-free quantum dots positions it to become a significant player in cleantech materials, facilitating collaborations with leading scientists in the region, particularly from Los Alamos and Sandia National Laboratories.
Qolab
Series A in 2024
Qolab mission is to build high quality qubits by leveraging the most advanced semiconductor manufacturing processes.
Inkbit
Venture Round in 2024
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of 3D printers. The company has developed an advanced additive manufacturing platform that integrates 3D printing with machine vision technology, allowing for the rapid production of polymer parts. By employing machine learning and artificial intelligence, Inkbit delivers a multi-material jetting platform that meets the speed and precision required for demanding industrial applications. The expertise of its team, comprised of MIT-trained scientists and engineers, spans industrial systems, design software, and material science, enabling Inkbit to bridge the gap between prototyping and large-scale manufacturing. This innovation facilitates the on-demand production of both multi-material and end-use products, positioning Inkbit as a leader in the mass-market additive manufacturing sector.
Trace
Pre Seed Round in 2024
Trace is the Canva for AR. The simplest way ever to make AR recordings and experiences for brands, retail, training and more. Partners include teams at Qualcomm, Deutsche Telekom, Lenovo, Telefonica and other fortune 500 companies. Contact us to work together or learn more. Info@Trace3d.app
Nanofiber Quantum Technologies
Convertible Note in 2023
Nanofiber Quantum Technologies is a research and manufacturing company focused on developing hardware for quantum communications. The company specializes in creating quantum computers that utilize nanofibers and advanced engineering techniques. Its primary areas of expertise include quantum cryptography and quantum communications, aiming to integrate these technologies into practical applications for societal benefit. By providing clients with innovative quantum networks, Nanofiber Quantum Technologies is advancing the field of quantum science and facilitating its implementation in various sectors.
FIGUR8
Series A in 2023
Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.
Ubicept
Seed Round in 2023
Ubicept is a computer vision company. They provide machine learning services by combining next-generation image sensors with computer vision algorithms. Their products include photon-counting cameras, edge photon processing, and a private developer portal.
Agrology
Seed Round in 2022
Agrology is an agricultural technology company recognized for its contributions to sustainable farming practices and a recipient of a National Science Foundation award. Operating from offices in Alexandria, Virginia, and Salinas, California, Agrology provides real-time data that enables growers to assess the ecological and agronomic impacts of regenerative farming. The company focuses on monitoring soil health, microbial activity, carbon cycles, nitrous oxide emissions, net ecosystem exchange, and microclimatic conditions. This data helps farmers connect regenerative practices to measurable reductions in greenhouse gases and other ecological benefits. Additionally, Agrology's predictive agriculture system offers insights that assist farmers in adapting to climate change while improving soil sequestration and generating carbon credits. The company is trusted by prominent growers, researchers, and global consumer packaged goods brands.
Profluent
Venture Round in 2022
Profluent Bio is an artificial intelligence-driven protein design company focused on creating innovative proteins that overcome existing industry challenges. By integrating advanced generative AI models with real-world laboratory characterization, Profluent combines machine learning techniques to analyze and engineer biomolecules. This approach supports biotechnology research and development, aiming to enhance human health and facilitate various industrial applications.
Biotia
Series A in 2022
Biotia, Inc. is a health tech company based in New York, founded in 2016. It specializes in developing software and laboratory technology that leverage next-generation DNA sequencing and artificial intelligence to enhance infectious disease discovery. Biotia's solutions focus on microbial surveillance and tailored sequencing to reduce hospital-acquired infections. By enabling clinicians and researchers to identify and stop pathogens before patients fall ill, Biotia aims to improve patient treatment and health outcomes, thereby contributing to safer healthcare environments.
Autonomic Materials
Venture Round in 2022
Autonomic Materials, Inc. specializes in the design, manufacture, and marketing of self-healing solutions for the coatings industry. The company produces microencapsulated additives that include both dual and single capsule systems, which utilize various chemical processes to repair coating damage at the micron level. These products provide corrosion protection and are applicable to a wide range of substrates, including metals, wood, concrete, plastics, and composites. Autonomic Materials' solutions are utilized in diverse sectors such as alternative energy, industrial maintenance, military equipment, infrastructure, and consumer paints. Founded in 2005 and based in Champaign, Illinois, the company focuses on enhancing the performance and longevity of materials by enabling them to respond to damage autonomously, thus reducing the need for manual detection and intervention.
Eclipse Bioinnovations
Series A in 2022
Eclipse Bioinnovations, founded in 2017 based on technology from the University of California, San Diego, specializes in RNA genomics. The company aims to advance RNA medicines and scientific discovery through its innovative platform technologies. Eclipse has developed eCLIP, a unique and efficient method for identifying RNA binding protein partners and gene maps. Its suite of RNA genomics technologies includes eCLIP-RBP for mapping RNA binding proteins, miR-eCLIP for studying the miR-interactome, m6A-eCLIP for RNA modifications, End-Seq for 5' and 3' mapping, and FLI-Seq for facilitating CRISPR library preparation. Eclipse offers these products as both services and kits, tailored for biopharma companies and academic researchers, enabling them to enhance their research and develop new therapies for various human diseases.
InVivo AI
Seed Round in 2021
InVivo AI, founded in 2017 and based in Montreal, Canada, specializes in utilizing artificial intelligence to enhance pharmaceutical research and development, particularly in the area of preclinical toxicology. The company aims to streamline the drug discovery process by implementing advanced AI methods for molecular representation and de novo design, which allows for the creation of novel chemical compounds that can address complex biological challenges. Through its innovative platform, InVivo AI is positioned to significantly improve the efficiency and effectiveness of drug design, paving the way for breakthroughs in pharmaceutical science.
Xandar Kardian
Series A in 2021
Xandar Kardian provides commercially deployed 99.9% 'true' presence detection and people (occupancy) count solutions for smart building applications. It's patented and proprietary occupancy count system is the world's first and only commercial grade system that is able to count from any open space (virtual zones), making foot traffic counting possible in areas that was not possible with traditional cameras. Using micro-vibration patterns emitted from the body (chest movement from breathing, heart beat frequency from the heart (BPM) movement inside the body), XK is able to obtain 95% repetitive accurate RHR and RR measurements continuously. Occupant wellness - either in an office space, factory, hospital, nursing home or residential homes is now possible continuously, autonomously and without using any cameras or wearable devices.
FibreCoat
Venture Round in 2021
FibreCoat GmbH specializes in the production of thermoplastic-coated glass fibers and aluminum-coated fibers intended for various composite and shielding applications. By utilizing rented glass fiber drawing machines, the company employs a direct coating process that streamlines manufacturing, reduces costs, and shortens cycle times while enhancing the technical specifications of its products. FibreCoat's offerings are particularly relevant to the automotive and consumer sectors, where they provide lightweight and cost-effective solutions. The company's metal-coated fiber components serve multiple functions, including electromagnetic interference shielding, heat sinks in battery casings, reinforcement for cast aluminum parts, and conductive yarns for smart textiles. Through these innovations, FibreCoat enables clients to achieve advanced material properties in their applications.
Inkbit
Series B in 2021
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of 3D printers. The company has developed an advanced additive manufacturing platform that integrates 3D printing with machine vision technology, allowing for the rapid production of polymer parts. By employing machine learning and artificial intelligence, Inkbit delivers a multi-material jetting platform that meets the speed and precision required for demanding industrial applications. The expertise of its team, comprised of MIT-trained scientists and engineers, spans industrial systems, design software, and material science, enabling Inkbit to bridge the gap between prototyping and large-scale manufacturing. This innovation facilitates the on-demand production of both multi-material and end-use products, positioning Inkbit as a leader in the mass-market additive manufacturing sector.
Green Theme Technologies
Venture Round in 2021
Green Theme Technologies Inc is a company that specializes in developing environmentally-friendly chemical technology for the finishing of textiles and nonwovens. Founded in 2012 and based in Rio Rancho, New Mexico, the company focuses on creating innovative products that enhance performance while significantly reducing water usage and pollution associated with traditional textile finishing processes. By prioritizing sustainability, Green Theme Technologies aims to revolutionize the textile industry with its advanced solutions.
Cotsworks
Venture Round in 2021
Cotsworks is a manufacturer specializing in rugged optical components designed for use in harsh environments across various sectors, including commercial, military, aerospace, and industrial markets. Established in 2006 and headquartered in Cleveland, Ohio, the company focuses on providing optical networking solutions that enhance navigation, threat detection, and control systems. By transitioning from traditional copper-based systems to optical networking, Cotsworks aims to improve operational efficiency and reliability in challenging conditions, serving the needs of both industrial and military clients.
L7 Informatics
Series B in 2021
L7 Informatics, Inc. specializes in providing integrated scientific data and analytics solutions aimed at enhancing the scientific process across various industries, including therapeutics, diagnostics, and agrochemicals. The company offers the L7 Enterprise Science Platform (L7|ESP®), which streamlines data management and workflow automation, enabling scientists and researchers to accelerate discoveries and improve operational efficiencies. By contextualizing data and facilitating digitalization, the platform helps eliminate business silos and enhances collaboration within life sciences organizations. L7 Informatics is committed to optimizing task execution and compliance, ultimately driving innovation and reducing costs in research and development processes.
Absci
Series E in 2020
Absci is a drug and target discovery company that utilizes deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. By employing its Integrated Drug Creation Platform, Absci identifies novel drug targets and discovers optimal biotherapeutic candidates while simultaneously generating the necessary cell lines for manufacturing. This innovative approach allows biotech and pharmaceutical partners to develop next-generation protein-based drugs, including Bionic Proteins that incorporate nonstandard amino acids and other unique drug designs that may be unattainable through traditional methods. Absci's mission focuses on advancing the development of improved medicines by effectively translating innovative ideas into viable drugs.
WaveDyn Vision
Venture Round in 2020
WaveDyn Vision is an early-stage medical device company with innovative wavefront diagnostic technology for use in the vision care industry. It plans to leverage its proprietary dynamic wavefront measurement technology to yield new insights into assessing visual performance, advancing treatment options, and improving the quality of life for the visually impaired. The company was founded in 2019 and is based in Albuquerque, New Mexico.
WaveFront Dynamics
Series A in 2020
WaveFront Dynamics is a medical device company specializing in advanced wavefront diagnostic technology tailored for the vision care sector. The company develops instruments that assess the visual performance of the human eye by measuring changes dynamically over time, rather than relying on a single snapshot. This innovative approach allows for comprehensive evaluations of the eye, facilitating improved treatment planning for complex visual dysfunctions. By leveraging dynamic wavefront measurement capabilities, WaveFront Dynamics aims to enhance the effectiveness of ophthalmic treatments and support healthcare professionals in delivering optimal patient care.
Micropore
Series C in 2020
Micropore manufactures reactive plastics which incorporate various powders into a molded matrix. The company's first product uses a CO2 adsorbent powder which is formed into a cartridge to create a revolutionary CO2 adsorbent system used in rebreathing and life support applications. The patented technology is the first major advance in CO2 adsorbent technology in over 100 years, providing superior performance advantages over existing granular adsorbents. It was founded in March of 1997 and is based in Elkton, Maryland.
Crop Enhancement
Series B in 2020
Crop Enhancement LLC is an innovative specialty materials company based in San Jose, California, founded in 2011. The company focuses on developing advanced formulation technologies for agricultural chemicals, which facilitate the controlled release of pesticides, herbicides, and fertilizers into targeted microenvironments. By employing environmentally friendly chemistry, Crop Enhancement aims to enhance crop yields and profitability while promoting sustainable farming practices. Its proprietary products include films that modify plant surfaces, improving resistance to pests and diseases. This technology not only reduces the reliance on synthetic pesticides but also ensures precise and effective delivery of active ingredients, contributing to a more sustainable approach to agriculture.
Absci
Series D in 2020
Absci is a drug and target discovery company that utilizes deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. By employing its Integrated Drug Creation Platform, Absci identifies novel drug targets and discovers optimal biotherapeutic candidates while simultaneously generating the necessary cell lines for manufacturing. This innovative approach allows biotech and pharmaceutical partners to develop next-generation protein-based drugs, including Bionic Proteins that incorporate nonstandard amino acids and other unique drug designs that may be unattainable through traditional methods. Absci's mission focuses on advancing the development of improved medicines by effectively translating innovative ideas into viable drugs.
BroadSpot Imaging Corporation
Series A in 2018
BroadSpot Imaging Corporation is developing a suite of diagnostic medical devices for eye care. They leverage advanced imaging technologies and small-scale, cloud-connected electronics to replace bulky, expensive diagnostic instruments with cost-effective handheld instruments and a series of valuable services. their technologies will fundamentally improve how eye care is delivered worldwide: eye doctors can see patients more efficiently, for less money, and more patients will gain access to high quality diagnostics as the population ages.
Absci
Series C in 2018
Absci is a drug and target discovery company that utilizes deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. By employing its Integrated Drug Creation Platform, Absci identifies novel drug targets and discovers optimal biotherapeutic candidates while simultaneously generating the necessary cell lines for manufacturing. This innovative approach allows biotech and pharmaceutical partners to develop next-generation protein-based drugs, including Bionic Proteins that incorporate nonstandard amino acids and other unique drug designs that may be unattainable through traditional methods. Absci's mission focuses on advancing the development of improved medicines by effectively translating innovative ideas into viable drugs.
Comera Life Sciences
Series A in 2018
Comera Life Sciences is a pre-clinical biotechnology company focused on transforming biologic medicines from intravenous to subcutaneous forms. The company utilizes its proprietary SQore platform, which includes patented, FDA-friendly excipients, to enhance the formulation of therapeutic biologics. This technology aims to make life-saving medicines easier to administer, reduce immunogenicity, increase stability, and improve production efficiency. Comera collaborates with pharmaceutical and biotechnology companies, applying its innovative techniques to optimize existing subcutaneous biologics and develop biosimilar versions of current products. Through these efforts, Comera Life Sciences seeks to improve treatment options for fragile patients and advance the field of formulation science.
Furcifer
Series A in 2017
Furcifer Inc., founded in 2015 and based in Menlo Park, California, is a venture-backed startup specializing in the development and manufacturing of advanced electrochromic films, commonly referred to as smart films. The company's technology is designed to transform traditional glass into smart glass, facilitating a variety of applications across multiple industries, including automotive, architecture, and electronic displays. By enabling control over the passage of light and heat, Furcifer's electrochromic films allow users to optimize energy efficiency, such as storing solar energy for powering lights. This innovative approach positions Furcifer at the forefront of sustainable technology solutions in the smart glass market.
BroadSpot Imaging Corporation
Series A in 2017
BroadSpot Imaging Corporation is developing a suite of diagnostic medical devices for eye care. They leverage advanced imaging technologies and small-scale, cloud-connected electronics to replace bulky, expensive diagnostic instruments with cost-effective handheld instruments and a series of valuable services. their technologies will fundamentally improve how eye care is delivered worldwide: eye doctors can see patients more efficiently, for less money, and more patients will gain access to high quality diagnostics as the population ages.
Absci
Series B in 2017
Absci is a drug and target discovery company that utilizes deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. By employing its Integrated Drug Creation Platform, Absci identifies novel drug targets and discovers optimal biotherapeutic candidates while simultaneously generating the necessary cell lines for manufacturing. This innovative approach allows biotech and pharmaceutical partners to develop next-generation protein-based drugs, including Bionic Proteins that incorporate nonstandard amino acids and other unique drug designs that may be unattainable through traditional methods. Absci's mission focuses on advancing the development of improved medicines by effectively translating innovative ideas into viable drugs.
C3Nano
Series D in 2017
C3Nano specializes in the development of transparent conductive inks and films designed to replace indium tin oxide (ITO) in touch sensors and displays. The company focuses on creating high-performance transparent conductor films and Activegrid silver nanowire solution-based inks, which provide enhanced scratch resistance, durability, and optical clarity. Their products are compatible with various substrates and processing techniques, addressing the growing demand for flexible touch sensor applications. Founded in 2010 and headquartered in Hayward, California, C3Nano has established a significant manufacturing presence in Korea and has raised $37 million in funding to advance its ink formulations and production capabilities.
Crop Enhancement
Series B in 2016
Crop Enhancement LLC is an innovative specialty materials company based in San Jose, California, founded in 2011. The company focuses on developing advanced formulation technologies for agricultural chemicals, which facilitate the controlled release of pesticides, herbicides, and fertilizers into targeted microenvironments. By employing environmentally friendly chemistry, Crop Enhancement aims to enhance crop yields and profitability while promoting sustainable farming practices. Its proprietary products include films that modify plant surfaces, improving resistance to pests and diseases. This technology not only reduces the reliance on synthetic pesticides but also ensures precise and effective delivery of active ingredients, contributing to a more sustainable approach to agriculture.
Nohms Technologies
Series B in 2016
NOHMs Technologies is developing materials and manufacturing processes for advanced lithium-ion battery electrolyte that enables twice the energy and runtime for half the cost in consumer electronics and electric vehicles via sales and licensing business model. The company's NanoLyte Electrolyte solutions contain new functional ionic liquid materials that significantly improve the performance and safety of next-generation lithium-ion batteries. NOHMs Technologies was founded in 2011 and is headquartered in Rochester, New York, United States.
Amber Molecular
Series A in 2016
Amber Molecular Inc. is a Canadian company founded in 2017 that specializes in developing innovative materials for organic light-emitting diodes (OLEDs). The company focuses on creating new light-emitting materials that are bright, rare earth metal-free, and available in a variety of colors, including orange to infrared. These materials feature narrow emissions that minimize perceived peak shifting, thus eliminating the need for filters in OLED applications. Amber Molecular aims to support businesses in the display sector and beyond by providing cost-effective solutions for advanced OLED technology.
Absci
Series A in 2016
Absci is a drug and target discovery company that utilizes deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. By employing its Integrated Drug Creation Platform, Absci identifies novel drug targets and discovers optimal biotherapeutic candidates while simultaneously generating the necessary cell lines for manufacturing. This innovative approach allows biotech and pharmaceutical partners to develop next-generation protein-based drugs, including Bionic Proteins that incorporate nonstandard amino acids and other unique drug designs that may be unattainable through traditional methods. Absci's mission focuses on advancing the development of improved medicines by effectively translating innovative ideas into viable drugs.
Sentinel Monitoring Systems
Series A in 2015
Sentinel Monitoring Systems, Inc. specializes in developing microbial monitoring systems tailored for the life sciences industry. Founded in 2014 and based in Tucson, Arizona, the company offers a range of products designed for rapid detection and control of microbial contamination. Its key offerings include the MOBA, an online bioburden monitoring system for ultra-pure and purified water systems; the ASP, an aseptic auto-sampler that collects samples based on online monitoring and scheduled intervals; and the OES, which automates the sampling and processing of endotoxin tests. Additionally, Sentinel features a near-real-time Fountain Flow Cytometry system for quantifying total bioburden. The company is focused on enhancing the scientific understanding and effectiveness of manufacturing processes within the medical and life sciences sectors.
C3Nano
Series C in 2014
C3Nano specializes in the development of transparent conductive inks and films designed to replace indium tin oxide (ITO) in touch sensors and displays. The company focuses on creating high-performance transparent conductor films and Activegrid silver nanowire solution-based inks, which provide enhanced scratch resistance, durability, and optical clarity. Their products are compatible with various substrates and processing techniques, addressing the growing demand for flexible touch sensor applications. Founded in 2010 and headquartered in Hayward, California, C3Nano has established a significant manufacturing presence in Korea and has raised $37 million in funding to advance its ink formulations and production capabilities.
NBD Nanotechnologies
Series A in 2014
NBD develops coatings and additives to modify surface wetting properties. NBD focuses on coatings and additives that modify surface wettability. NBD's broad product portfolio can influence surface properties for glass and plastic materials to create ultra-durable and functional surface wetting properties. It was founded in 2012 and headquartered in Brighton, Massachusetts.
Imprint Energy
Series A in 2014
Imprint Energy, Inc. develops and commercializes innovative zinc-based rechargeable battery technology aimed at enhancing portable power solutions. The company offers ZincPoly batteries, which address the limitations of traditional zinc batteries and enable the production of rechargeable options. These batteries are designed for a variety of small portable electronics, including mobile accessories, compact wireless devices, wearables, and medical equipment. Founded in 2010 and based in Alameda, California, Imprint Energy focuses on providing flexible, high-energy-density batteries that deliver lithium-like performance at lower costs, while also prioritizing safety and scalability through a unique print-based manufacturing process. This breakthrough technology positions Imprint Energy to meet the evolving energy needs of contemporary and future electronic devices.
Autonomic Materials
Series B in 2012
Autonomic Materials, Inc. specializes in the design, manufacture, and marketing of self-healing solutions for the coatings industry. The company produces microencapsulated additives that include both dual and single capsule systems, which utilize various chemical processes to repair coating damage at the micron level. These products provide corrosion protection and are applicable to a wide range of substrates, including metals, wood, concrete, plastics, and composites. Autonomic Materials' solutions are utilized in diverse sectors such as alternative energy, industrial maintenance, military equipment, infrastructure, and consumer paints. Founded in 2005 and based in Champaign, Illinois, the company focuses on enhancing the performance and longevity of materials by enabling them to respond to damage autonomously, thus reducing the need for manual detection and intervention.
Vixar
Series B in 2012
Vixar Inc. is a manufacturer based in Plymouth, Minnesota, specializing in short wavelength vertical cavity surface emitting laser (VCSEL) and LED-based optical components and subassemblies. Founded in 2005 by Dr. Klein Johnson and Dr. Mary Hibbs-Brenner, the company focuses on providing high-performance, cost-effective VCSEL products that emit wavelengths from 660 to 1850 nm. Vixar's components are designed to enhance performance, size, and energy efficiency for applications across various industries, including biomedical, industrial, military, automotive, office products, and consumer goods. The company operates as a subsidiary of OSRAM Licht AG, continuing its mission to deliver innovative optoelectronic solutions tailored to meet the demands of modern technology.
C3Nano
Series B in 2012
C3Nano specializes in the development of transparent conductive inks and films designed to replace indium tin oxide (ITO) in touch sensors and displays. The company focuses on creating high-performance transparent conductor films and Activegrid silver nanowire solution-based inks, which provide enhanced scratch resistance, durability, and optical clarity. Their products are compatible with various substrates and processing techniques, addressing the growing demand for flexible touch sensor applications. Founded in 2010 and headquartered in Hayward, California, C3Nano has established a significant manufacturing presence in Korea and has raised $37 million in funding to advance its ink formulations and production capabilities.
Senova Systems
Series B in 2012
Senova Systems, Inc. is a company based in Sunnyvale, California, that specializes in the development, manufacturing, and sale of pH meters for various industries, including life sciences, food and beverage, dairy, water, and consumer products. Founded in 2007, the company has introduced an innovative calibration-free pHit™ pH sensor platform that utilizes non-glass electrodes, marking a significant advancement in pH measurement technology. This solid-state sensor replaces traditional glass electrodes and does not require user calibration, facilitating novel applications in healthcare and other specialized fields that were previously unattainable with conventional pH measurement methods. Senova Systems aims to provide reliable and advanced pH measurement solutions to enhance various scientific and industrial processes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.